Cellular immunogenicity and immunotoxicity assays help scientists design, validate, and translate therapeutic research into treatments that weaponize the immune response against cancer.

It can precisely select single cells on a chip, carry out several single-cell assays, and export target cells based on particular outcomes. The Beacon ® optofluidic platform maintains the ...

Move into cellular assays Biochemical assays help solve some of the mystery behind an inhibitor’s activity and specificity, but they explain little about what a specific kinase inhibitor binds ...

It is these events that determine whether the cell cycle will go forward or remain stalled between stages. Here we focus on the transformation assay, which scientists first used to identify ...

With over 15 years of experience in kinase drug discovery, DiscoverX offers the largest collection of nearly 500 biochemical and cell-based kinase assays. KINOMEscan® technology, our novel kinase ...

In this webinar brought to you by Lonza, Ethan Shelkey and Aurita Menezes will discuss the effects of donor variability in cell-based assays for measuring drug immunogenicity and immunotoxicity. The ...